Cell and Gene Outsourcing

1. Are You Still Evaluating CMOs When You Really Need A CDMO? 10/29/2025

   Outsourcing adds capacity and specialized knowledge to your supply chain. But contractors come in several types. Here's how to pick the right one.

2. Achieve Efficient Viral Vector Production At Any Phase 10/28/2025

   The Challenge: Building Scalable Viral Vector Programs

   Cell and gene therapies offer unprecedented hope for previously untreatable diseases. At the heart of many of these advanced therapies, including both gene therapies and gene-modified cell therapies, are viral vectors, particularly Adeno-Associated Vectors (AAV) and Lentiviral Vectors (LVV), which serve as crucial gene-delivery vehicles.

3. Program Manager Alignment And Integration: Best Practices When Working With A CDMO 10/23/2025

   This Q&A discusses best practices for integrating program managers into a sponsor company and how program managers help bridge the gaps between various stakeholders.

4. A Strategic Enabler For Scaling Gene Therapies 10/22/2025

   Platform-based manufacturing uses standardized, pre-qualified workflows and analytics that reduce variability, simplify regulatory submissions, and accelerate the path to commercial success.

5. How In-House CDMO Analytics Reduce Risk and Cost 10/21/2025

   Integrated analytical capabilities within a CDMO are increasingly preferred to overcome challenges associated with outsourcing analysis in biopharma development and manufacturing.

6. The 9 Fastest-Growing Outsourcing Segments 10/21/2025

   Capacity isn’t the choke point—capability is; this piece ranks nine fast-growing outsourcing segments and shows sponsors how to win by locking in modality-proven partners early.

7. Collaboration An Untapped Fuel For Driving Biopharma R&D 10/20/2025

   Biopharma’s future depends on collaboration. Discover how cross-industry partnerships and shared resources can accelerate innovation, overcome talent gaps, and strengthen the global R&D ecosystem.

8. Partnering To Advance Therapeutic Innovation: Clinical Trial Solutions 10/20/2025

   A global network supports clinical trials with integrated services including bioanalysis, central laboratory safety testing, pathology, and clinical supplies. Solutions cover every phase of drug development.

9. How Global Supply Chain Centers Amplify CGT Program Growth 10/20/2025

   Consolidating logistics, cryopreservation, and storage eliminates handoffs and risk. This single-platform approach creates the consistency needed for global compliance and growth.

10. Hidden Risks In Your Supply Chain: Regulatory Support Can Save Your CGT 10/20/2025

    Unvalidated shipping lanes and incomplete documentation can cause regulatory delays. Proactive qualification and risk assessments are vital for compliance and safeguarding product integrity.